.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Zaleplon - Generic Drug Details

« Back to Dashboard
Zaleplon is the generic ingredient in two branded drugs marketed by Cipla Ltd, Upsher Smith, Aurobindo Pharma, West-ward Pharms Int, Mylan, Teva Pharms, Hikma Pharms Llc, Pfizer, Orchid Hlthcare, Unichem, and Upsher-smith Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for zaleplon. Twenty-five suppliers are listed for this compound.

Summary for Generic Name: zaleplon

Tradenames:2
Patents:0
Applicants:11
NDAs:11
Drug Master File Entries: see list12
Suppliers / Packagers: see list25
Bulk Api Vendors: see list50
Clinical Trials: see list5
Patent Applications: see list1,752
Therapeutic Class:Sedatives/Hypnotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zaleplon at DailyMed

Pharmacology for Ingredient: zaleplon

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
ZALEPLON
zaleplon
CAPSULE;ORAL077237-002Jun 6, 2008RXNo► subscribe► subscribe
Unichem
ZALEPLON
zaleplon
CAPSULE;ORAL078989-001Jun 6, 2008RXNo► subscribe► subscribe
Mylan
ZALEPLON
zaleplon
CAPSULE;ORAL077238-001Jun 6, 2008RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zaleplon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-001Aug 13, 19994,626,538► subscribe
Pfizer
SONATA
zaleplon
CAPSULE;ORAL020859-002Aug 13, 19994,626,538► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc